Industry Circle

The Thalassaemia International Federation (TIF) Industry Circle, officially launched in 2012, is a network of pharmaceutical industries that share a common interest in haemoglobin disorders (thalassaemia and sickle cell disease) and in the development of technologies relating to their prevention, treatment and monitoring.

In the Federation’s efforts to sustain and strengthen the relationship with our industry partners, the Industry Circle has provided a platform for the exchange of knowledge and expertise between research and patients, reinforcing the Federation’s efforts to sustain and strengthen the relationship with our industry partners.

Pursuing the same goal, TIF seeks to obtain an open and transparent relationship with the industry, not only as supporters but also as allies in this relentless struggle to achieve equal access to all patients with haemoglobin disorders across the world to timely and quality healthcare.

TIF receives funding from the following companies and organisations through Donations, Project funding, International conferences, Memberships, subscriptions and others.

 See breakdown of TIF Funding